Publications
Showing entries 81 - 100 out of 102
2014
Meier SM, Novak MS, Kandioller W, Jakupec MA, Roller A, Keppler BK et al. Aqueous chemistry and antiproliferative activity of a pyrone-based phosphoramidate Ru(arene) anticancer agent. Dalton Transactions. 2014;43(26):9851-9855. doi: 10.1039/c4dt00569d
Pichler V, Göschl S, Meier SM, Roller A, Jakupec M, Galanski MS et al. Asymmetric and symmetric PtIV complexes: new insights into the influence of the equatorial ligands sphere on reactivity and stability. Journal of Biological Inorganic Chemistry. 2014;19 Suppl.:S598.
Meier SM, Hanif M, Adhireksan Z, Pichler V, Novak M, Jirkovsky E et al. Novel Metal(II) Arene 2-Pyridinecarbothioamides (PCAs): A Rationale to Orally Active Organometallic Anticancer Agents. Journal of Biological Inorganic Chemistry. 2014;19(Suppl. 1):587. doi: https://doi.org/10.1007/s00775-014-1095-8
Fischer B, Heffeter P, Kryeziu K, Gille L, Meier SM, Berger W et al. Poly(lactic acid) nanoparticles of the lead anticancer ruthenium compound KP1019 and its surfactant-mediated activation. Dalton Transactions. 2014;43(3):1096-1104. doi: 10.1039/c3dt52388h
2013
Hanif M, Meier SM, Nazarov AA, Risse J, Legin A, Casini A et al. Influence of the π-coordinated arene on the anticancer activity of ruthenium(II) carbohydrate organometallic complexes. Frontiers in Chemistry. 2013 Oct 31;1:27. doi: 10.3389/fchem.2013.00027
Primik MF, Goeschl S, Meier SM, Eberherr N, Jakupec MA, Enyedy EA et al. Dicopper(II) and Dizinc(II) Complexes with Nonsymmetric Dinucleating Ligands Based on Indolo[3,2-c]quinolines: Synthesis, Structure, Cytotoxicity, and Intracellular Distribution. Inorganic Chemistry. 2013 Sep 2;52(17):10137-10146. doi: 10.1021/ic401573d
Pichler V, Goeschl S, Meier SM, Roller A, Jakupec MA, Galanski MS et al. Bulky N(,N)-(Di)alkylethane-1,2-diamineplatinum(II) Compounds as Precursors for Generating Unsymmetrically Substituted Platinum(IV) Complexes. Inorganic Chemistry. 2013 Jul 15;52(14):8151-8162. doi: 10.1021/ic400816g
Meier SM, Novak M, Kandioller W, Jakupec MA, Arion VB, Metzler-Nolte N et al. Identification of the Structural Determinants for Anticancer Activity of a Ruthenium Arene Peptide Conjugate. Chemistry: A European Journal. 2013 Jul 8;19(28):9297-9307. doi: 10.1002/chem.201300889
Gavriluta A, Novak M, Tommasino JB, Meier SM, Jakupec MA, Luneau D et al. Osmium-nitrosyl complexes with glycine, picolinic acid, L -proline and D -proline: Synthesis, structures and antiproliferative activity. Zeitschrift für Anorganische und Allgemeine Chemie. 2013 Jul 1;639(8-9):1590-1597. doi: 10.1002/zaac.201300054
Grabmann G, Meier SM, Scaffidi-Domianello Y, Pichler V, Keppler B, Hartinger CG. The Aqueous Chemistry of Pt(II) Complexes under Physiologically Relevant Conditions Studied by Means of CZE–UV and CZE–ESI-MS. In Konferenzband. 2013
Babak M, Meier SM, Legin A, Adib Razavi MS, Roller A, Jakupec M et al. Am(m)ines Make the Difference: Organoruthenium Am(m)ine Complexes and Their Chemistry in Anticancer Drug Development. Chemistry: A European Journal. 2013;19(13):4308-4318. doi: 10.1002/chem.201202657
Hartinger CG, Größl M, Meier SM, Casini A, Dyson PJ. Application of mass spectrometric techniques to delineate the modes-of-action of anticancer metallodrugs. Chemical Society Reviews. 2013;42(14):6186-6199. doi: 10.1039/c3cs35532b
Meier SM, Hanif M, Adhireksan Z, Pichler V, Novak M, Jirkovsky E et al. Novel metal(II) arene 2-pyridinecarbothioamides: a rationale to orally active organometallic anticancer agents. Chemical Science. 2013;4(4):1837-1846. doi: 10.1039/c3sc22294b
Meier SM, Pichler V, Novak M, Jirkovsky E, Jakupec MA, Anon VA et al. Novel Metal(II)-Arene 2-Pyridinecarbothioamides: A Rationale to Orally Active Organometallic Anticancer Agents. Chemical Science. 2013;4:1837-1846. doi: https://doi.org/10.1039/C3SC22294B
Kandioller W, Balsano E, Meier SM, Jungwirth U, Göschl S, Roller A et al. Organometallic anticancer complexes of lapachol: metal centre-dependent formation of reactive oxygen species and correlation with cytotoxicity. Chemical Communications. 2013;49(32):3348-3350. doi: 10.1039/c3cc40432c
Büchel G, Gavriluta A, Novak M, Meier SM, Jakupec M, Cuzan O et al. Striking Difference in Antiproliferative Activity of Ruthenium- and Osmium-Nitrosyl Complexes with Azole Heterocycles. Inorganic Chemistry. 2013;52(11):6273-6285. doi: 10.1021/ic400555k
2012
Meier SM, Kandioller W, Keppler B, Hartinger C. Biomolecule binding vs. anticancer activity: Reactions of Ru(arene)[(thio)pyr-(id)one] compounds with amino acids and proteins. Journal of Inorganic Biochemistry. 2012;108:91-95. doi: 10.1016/j.jinorgbio.2011.08.011
Grabmann G, Meier SM, Scaffidi-Domianello Y, Galanski MS, Keppler B, Hartinger CG. Capillary zone electrophoresis and capillary zone electrophoresis-electrospray ionization mass spectrometry studies on the behavior of anticancer cis- and trans-[dihalidobis(2-propanone oxime)platinum(II)] complexes in aqueous solutions. Journal of Chromatography A. 2012;1267(SI):156-161. doi: 10.1016/j.chroma.2012.07.062
Meier SM, Tsybin YO, Dyson PJ, Keppler B, Hartinger C. Fragmentation methods on the balance: unambiguous top-down mass spectrometric characterization of oxaliplatin-ubiquitin binding sites. Analytical and Bioanalytical Chemistry. 2012;402(8):2655-2662.
2011
Hanif M, Meier SM, Kandioller W, Bytzek A, Hejl M, Hartinger CG et al. From hydrolytically labile to hydrolytically stable Ru-II-arene anticancer complexes with carbohydrate-derived co-ligands. Journal of Inorganic Biochemistry. 2011 Feb;105(2):224-231. doi: 10.1016/j.jinorgbio.2010.10.004
Showing entries 81 - 100 out of 102